CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT - Wikidata - awgldk - TriplyDB

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

http://www.wikidata.org/entity/Q56880248

about

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer Does facilitated Advance Care Planning reduce the costs of care near the end of life? Systematic review and ethical considerations Cost-effectiveness modelling in diagnostic imaging: a stepwise approach The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review Defining a staged-based process for economic and financial evaluations of mHealth programs.The SITLESS project: exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: study protocol for a randomised controlled trial.The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.Pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: A trial protocol (A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development.Quality of pharmacoeconomic research in China: A systematic review Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?2014 consensus statement from the first Economics of Physical Inactivity Consensus (EPIC) conference (Vancouver).Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses.The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.Effectiveness of electrocardiographic guidance in CVAD tip placement.Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review.Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis.ECONOMIC EVALUATION STUDIES OF SELF-MANAGEMENT INTERVENTIONS IN CHRONIC DISEASES: A SYSTEMATIC REVIEW.HEALTH TECHNOLOGY ASSESSMENTS REPORTING COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION.CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer Cost-effectiveness of the Cardiac Component of the Focused Assessment of Sonography in Trauma Examination in Blunt Trauma.Cost-analysis of robotic-assisted laparoscopic hysterectomy versus total abdominal hysterectomy for women with endometrial cancer and atypical complex hyperplasia.Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin.Study protocol for the 'HelpMeDoIt!' randomised controlled feasibility trial: an app, web and social support-based weight loss intervention for adults with obesity.Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).Cost analysis of breast cancer diagnostic assessment programs.Effectiveness, costs and cost-effectiveness of chiropractic care and physiotherapy compared with information and advice in the treatment of non-specific chronic low back pain: study protocol for a randomised controlled trial.Physical activity and the prevention, reduction, and treatment of alcohol and/or substance use across the lifespan (The PHASE review): protocol for a systematic review.Clinical decision analysis in perinatology.Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.Who should conduct modeling and cost-effectiveness analysis?Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence.An economic evaluation of an integrated care pathway in geriatric rehabilitation for older patients with complex health problems.A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.Cost-Effectiveness of Product Reformulation in Response to the Health Star Rating Food Labelling System in Australia.Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment

P2860

Q26748855-401ACC2B-A887-4BF4-A80F-0E4EF61A4165 Q26796231-343E1620-6420-48E4-928C-61FCB6EC20E8 Q26823853-D24E31A6-96F7-4638-A3FD-E020C7B86305 Q28973596-33AAF496-A0FA-4287-BF99-E7ABFD4EF581 Q33568594-B20E76E5-82C1-45C8-86A8-AD138E602A42 Q33705908-9FF5BE20-F21A-4124-A2B8-81E7D03EC1CD Q33855920-2BE68979-5D0D-480A-89E2-97590F88424D Q35531880-FA52DFAE-B8E2-4CBD-981C-9BAF348AFD6B Q36302726-F4CA0C13-CFCC-4DCD-A7F0-6620BFE2B455 Q36305079-0449548B-CF9B-42DA-B2FB-1EE88FFCB1F7 Q37352181-F1937ED4-6434-463F-B373-48C9CFD65D73 Q37354823-B2C29AFB-70AF-44DB-88B9-7DE16C6D53A5 Q38210051-3D0B4C3F-45CD-43AE-AE59-6F162B267352 Q38214502-918F9DE3-0081-430F-8C00-00F1774FBF4A Q38254978-E9F7B942-44B7-4CCE-A4DC-803A00B3F923 Q38284334-33E15D36-5264-4303-BBC6-B2E4F844EE72 Q38552643-BC50D2CF-1E3B-4802-B7A1-39063FC708AF Q38713953-FBC1B3CE-108E-4A82-9A62-14763B348015 Q38727828-E81F6BE8-9AC9-4474-ADCA-59A3F4FADE43 Q38820067-E2259972-8590-4D34-88FC-491B543A6DFB Q38918657-10E1DF2D-ABE9-47F2-B536-47A161E0E9E4 Q39391982-31FE1B69-25A4-420B-98A2-158594505B6E Q39423484-BB75922C-9134-42CE-B1F1-524D6D13ECE7 Q40012702-B3CE8355-9B31-4772-917A-870FE6108664 Q40313924-F06B5479-65E9-4391-8BD9-084980EA7DA9 Q41288731-2762E43F-95B4-4BB1-8C78-B8A699620145 Q42699408-15916B71-5865-4B47-85DF-4165E69FE9D9 Q47123934-0168C7FD-C902-4136-B5FF-6B67BA5561AC Q47138891-E11D5433-4779-4C7F-A906-962D8EE2FD58 Q47139536-D39EDB95-CFC0-4A98-B6A1-B8C2174B48EE Q47557909-145FBFFA-136E-4389-B0D9-6D18E3A83E92 Q48257070-CCD2661B-BF50-43B9-B358-4294637F2A36 Q48374688-8AF0C795-B12E-440D-B69E-52427A8A56DE Q50690327-860DCE31-5CD2-4B94-8431-445DB44AF59F Q51035093-1BA0C4A4-7D31-4F41-970C-4BFF47E07292 Q52315927-D64F7B94-150A-48A4-9CCB-0147E98186AA Q53699968-7BA00F0E-7DEA-4B2A-A2DA-D2B37EB7355E Q53818394-3C999B65-DCBA-422A-8217-6F4FBC3DC3EB Q55251259-60CEE2F5-F32A-45F4-BB52-2171E6E76FC7 Q59132647-06F64CD0-515E-4668-94CB-9A7EA14A8765

P2860

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

http://www.wikidata.org/entity/Q56880248

description

article

@en

im April 2013 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2013

@uk

name

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

@en

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS

@nl

type

label

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

@en

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS

@nl

prefLabel

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

@en

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS

@nl

P1433

Q56880248-DA27E70D-4CA4-462A-BA41-03919DA9CDBA

P1476

Q56880248-F4420AD6-5544-42D8-8C93-3EF42D2CB839

P2093

Q56880248-18FD6A43-023C-421B-A164-C16368250A65

Q56880248-1999E104-FE9A-43D2-B1BD-F5650518BD16

Q56880248-2CF9F022-870D-4D08-98CB-9308FDC05EDE

Q56880248-57FC2528-9738-47A1-95BF-9A2A2A01A1E0

Q56880248-67097256-C514-42EB-A8B4-0584BC9B5073

Q56880248-DBCFF2E9-AEEF-4BFB-AAEE-36BF6F215CE6

P2860

Q56880248-25DB71CE-EF5C-42E8-BE12-7A99A3439163

Q56880248-57496922-577E-4551-8F6D-7B4EC13FBF30

Q56880248-5CA6EC52-A689-4B96-B698-5B52959E095A

Q56880248-5D2C5A4B-978A-481D-ACFB-8C929DC51753

Q56880248-6C8BD23C-4E79-46B8-8065-C7BF36859E7D

Q56880248-6D659E89-5E07-455D-A863-45E210538BF6

Q56880248-788192E5-0E35-4940-860F-DEF97C830382

Q56880248-940639E4-82F9-472A-AE86-BFDA79831296

Q56880248-A3042967-9E43-4261-9778-F52C39CC51AA

Q56880248-C5E0BD1C-2AF6-4FEF-8285-DFF3E3E3B4E3

P304

Q56880248-7B7E341B-2D3D-4E97-9C1E-4D888A2088FF

P31

Q56880248-6220870C-8D00-45EA-BB44-B4FC4CDF2E7D

P356

Q56880248-4279DB7F-92E8-4002-AC62-9AB84ED6E089

P433

Q56880248-74C612F4-2F8F-4BD3-88F5-11EA815DE6C4

P478

Q56880248-5322D4DB-8CAB-467A-8AF4-BA79ECC96506

P50

Q56880248-1DE0B752-EAF4-451B-8704-111353DF168F

Q56880248-4EDD4F6C-E6BB-4F12-8333-569AE3FA003A

Q56880248-CE961353-0E9A-4BE1-B374-43C73A7294C8

Q56880248-FE3955D7-811B-429C-9427-03A6726D4E1B

P577

Q56880248-B7DE31D8-336E-4360-83E6-A224F4244F26

P698

Q56880248-840946A8-9DA7-4668-BFFE-42466FE8F078

P356

S0266462313000160

P1433

International Journal of Technology Assessment in Health Care

P1476

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

@en

P2093

Andrew H Briggs

http://www.w3.org/2001/XMLSchema#string

Chris Carswell

http://www.w3.org/2001/XMLSchema#string

Elizabeth Loder

http://www.w3.org/2001/XMLSchema#string

Federico Augustovski

http://www.w3.org/2001/XMLSchema#string

Josephine Mauskopf

http://www.w3.org/2001/XMLSchema#string

Michael Drummond

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Guidance for developers of health research reporting guidelines.

The quality of reporting in published cost-utility analyses, 1976-1997.

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review

Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting.

Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics.

Quality of abstracts of papers reporting original cost-effectiveness analyses.

Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

P304

117-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462313000160

http://www.w3.org/2001/XMLSchema#string

P433

02

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23587340

http://www.w3.org/2001/XMLSchema#string